Ciprofloxacin and suicidality: a nested case-control study in UK primary care using the Clinical Practice Research Datalink

Why was this study done?

Some doctors and researchers have wondered if a group of antibiotics called fluoroquinolones might be linked to suicidal behaviour. Previous studies have given mixed results. This study looked at whether people taking ciprofloxacin (a common fluoroquinolone antibiotic) were more likely to attempt or die by suicide than people taking other types of antibiotics.

What did the researchers do?

The researchers used health records from adults in the UK who were treated for chest infections, urine infections, or prostate infections between 1998 and 2021. They compared people who had attempted or died by suicide with similar people who had not. They then checked which antibiotics had been prescribed in the weeks before these events.

What did they find?

People who had attempted or died by suicide were more likely to have recently been prescribed ciprofloxacin, rather than another antibiotic compared to people who did not have suicidal behaviours. The increased risk was strongest when the prescription for antibiotics was in the last week and became smaller when the prescription was longer ago. Other fluoroquinolone antibiotics showed a similar pattern, but the evidence was less certain. Deaths by suicide were uncommon, so it was difficult to study them separately.

What does this mean?

The study suggests that ciprofloxacin may be linked to a small increase in the risk of suicidal behaviour. Importantly, although we took account of a range of other factors, we can't say for certain whether the ciprofloxacin caused this increase in suicidal behaviour. It could have been something we were not able to account for. Doctors should be aware of possible changes in mood, thoughts, or behaviour in patients taking these medicines and continue to prescribe antibiotics carefully, continuing to carefully weigh the risks and benefits. Ciprofloxacin remains a useful antibiotic for treating difficult infections. More research is needed to understand why this link might exist and whether changes to prescribing practices are needed.